BDXのチャート
BDXの企業情報
| symbol | BDx |
|---|---|
| 会社名 | Becton Dickinson_Co （BDX ベクトン・ディッキンソン） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 ベクトン・ディッキンソン（Becton Dickinson and Company）は医療用品、装置、実験装置および診断用製品を開発・製造・販売するグローバルな医療技術会社である。同社はBD医療事業とBD生命科学事業を運営する。BD医療事業は、各種のセッティングでヘルスケア提供を改善するために使用される一連の医療技術と医療機器を製造する。同事業は、糖尿病ケア、投薬および手続きソリューション、投薬管理ソリューション、医薬品システムなど、各ビジネスユニットで構成される。BD生命科学事業は感染症、医療関連感染症、およびがんを検出するために、診断標本、器具および試薬システムを安全に収集・輸送するための製品を提供する。同事業は、診断システム、バイオサイエンスなど、各ビジネスユニットが含まれる。 ベクトン・ディッキンソンは医療機器、検査室用器材、抗体、試薬、診断用製品を製造する。事業は3部門で構成。メディカル部門は注射針、静脈内カテ―テル、薬剤充填済みキット製品などを提供。ダイアグノスティクス部門は病院向けに採血管・キット、子宮頸がん診断用細胞検診製品など、またバイオサイエンス部門は乾細胞解析・分離装置などを製造する。 BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. |
| 本社所在地 | 201 847-6800 |
| 代表者氏名 | Vincent A. Forlenza |
| 代表者役職名 | Chairman of the Board Chief Executive Officer |
| 電話番号 | +1 201-847-6800 |
| 設立年月日 | 1897年 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 50928人 |
| url | www.bd.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | EBITDA（百万ドル） 4886.00000 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | 時価総額（百万ドル） 67193.20000 |
| 売上高 | 売上高（百万ドル） 17062.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 87318.20000 |
| 当期純利益 | 当期純利益（百万ドル） 1316.00000 |
| 決算概要 | 決算概要 BRIEF: For the three months ended 31 December 2018 Becton Dickinson and Co revenues increased 35% to $4.16B. Net income applicable to common stockholders excluding extraordinary items increased from $96M to $613M. Revenues reflect Interventional segment increase from $183M to $970M Medical segment increase of 15% to $2.14B United States segment increase of 44% to $2.39B International segment increase of 25% to $1.77B. |
BDXのテクニカル分析
BDXのニュース
Becton, Dickinson Shares Dip Despite Q2 Earnings Beat 2023/05/05 13:07:14 Bitcoin Ethereum News
The post Becton, Dickinson Shares Dip Despite Q2 Earnings Beat appeared on BitcoinEthereumNews.com . Becton, Dickinson, and Company (NYSE: BDX) posted profits of $460 million, equivalent to $2.86 per share, beating the consensus of $2.74. BD reported sales of $4.82 billion, up 1.5% Y/Y, beating the…
Citi maintains Becton Dickinson at Neutral with a price target of $260.00 2023/05/05 09:12:37 Investing.com
https://www.investing.com/news/pro/becton-dickinsn-receives-investment-bank-analyst-rating-update-3074091
Piper Sandler Upgrades Becton Dickinson to Overweight 2023/05/05 07:53:02 Investing.com
https://www.investing.com/news/pro/piper-sandler-upgrades-becton-dickinson-to-overweight-432SI-3074018
TD Cowen maintains Becton Dickinson at Market Perform with a price target of $271.00 2023/05/05 01:17:37 Investing.com
https://www.investing.com/news/pro/becton-dickinsn-receives-investment-bank-analyst-rating-update-3073854
Becton, Dickinson Shares Dip Despite Q2 Earnings Beat - Here''s The Deatils 2023/05/04 17:21:27 Benzinga
Becton, Dickinson, and Company (NYSE: BDX ) posted profits of $460 million, equivalent to $2.86 per share, beating the consensus of $2.74 . BD reported sales of $4.82 billion, up 1.5% Y/Y, beating the consensus of $4.68 billion. The company''s medical segment reported 9.6% growth, and its interventional business grew by 6.8%. Life sciences revenue offset that growth, dropping by 14.2%. That segment''s performance … Full story available on Benzinga.com
Becton Dickinson PT Raised to $260 at Piper Sandler 2023/02/03 11:40:08 Investing.com
https://www.investing.com/news/pro/becton-dickinson-pt-raised-to-260-at-piper-sandler-432SI-2994873
Top 5 4th Quarter Trades of TOBAM 2023/02/02 20:00:16 GuruFocus
Related Stocks: EA , UTHR , BDX , TTWO , LVS ,
Becton, Dickinson and Company (BDX) Q1 2023 Earnings Call Transcript 2023/02/02 16:27:10 Seeking Alpha
Becton, Dickinson and Company (NYSE:NYSE:BDX) Q1 2023 Earnings Conference Call February 2, 2023 8:00 AM ETCompany ParticipantsFrancesca DeMartino – Senior Vice President and Head-Investor…
Becton, Dickinson and Company 2023 Q1 - Results - Earnings Call Presentation (NYSE:BDX) 2023/02/02 13:31:06 Seeking Alpha
The following slide deck was published by Becton, Dickinson and Company in conjunction with their 2023 Q1 earnings call.
Becton Dickinson earnings beat by $0.30, revenue topped estimates By Investing.com 2023/02/02 11:43:00 Investing.com
Becton Dickinson earnings beat by $0.30, revenue topped estimates
Watch this stock’s price performance: Becton Dickinson and Company (NYSE:BDX) 2022/08/01 17:12:00 US Post News
Becton Dickinson and Company (BDX)’s stock is trading at $244.14 at the moment marking a fall of -0.07% from the last session close. As of this writing, shares are priced at -11.95% less than their 52-week high of $277.29, and 6.50% over their 52-week low of $229.24. Based on the past 30-day period, the stock […]
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $8,800 Today 2022/07/28 16:00:23 Benzinga
Becton, Dickinson (NYSE: BDX ) has outperformed the market over the past 20 years by 3.42% on an annualized basis producing an average annual return of 11.36%. Currently, Becton, Dickinson has a market capitalization of $68.64 billion. Buying $1000 In BDX: If … Full story available on Benzinga.com
Becton, Dickinson acquires MedKeeper to offer cloud-based, connected pharmacy software 2022/07/28 11:35:02 Seeking Alpha
Becton, Dickinson (BDX) acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications, for providing customers with flexibility and capabilities in meeting…